Why is Trident Texofab falling/rising?

As of 29-Aug, Trident Texofab Ltd's stock price is rising, currently at Rs. 252.90, reflecting an increase of 6.15 (2.49%). The stock has recently hit a new 52-week and all-time high of Rs. 255, and it has outperformed its sector by 1.86%. Over the past two days, the stock has gained 6.51%, and it opened with a gain of 3.34% today. Trident Texofab has shown impressive returns, with a 456.44% increase over the past year and a 50.36% rise year-to-date, significantly outperforming the Sensex, which has seen a decline of 2.83% over the same period. The company has also reported positive results for the last three consecutive quarters, with net sales growing by 24.20%, contributing to the stock's upward momentum.
In the broader market context, while the Sensex has experienced a decline of 1.84% over the past week, Trident Texofab's stock has risen by 9.60%, showcasing its strong performance relative to the benchmark. This divergence highlights the stock's resilience and investor confidence, particularly given its majority non-institutional shareholder base and consistent positive financial results. The rising investor participation, indicated by a 33.42% increase in delivery volume, further supports the stock's upward trajectory, suggesting robust demand amidst a challenging market environment.